Zentalis Pharmaceuticals, Inc. (NasdaqGM: ZNTL)
Health Care · Biotechnology · US
$3.83
+7.44% today · +110.2% 1Y
Zentalis Pharmaceuticals, Inc. (NasdaqGM: ZNTL) operates in the Biotechnology industry within the Health Care sector. The company is valued at $362.12M and employs 106 people.
Over the last twelve months the share price has gained 110.2%, trading between 1.21 and 6.95.
Tweenvest scores Zentalis Pharmaceuticals, Inc. across four factors: quality 29/100. Its strongest factor is quality.
ZNTL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $362.12M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.96
- Dividend yield
- —
- Beta (5Y)
- 1.89
- 52-week high
- $6.95
- 52-week low
- $1.21
- Avg volume (3M)
- —
- Shares outstanding
- 94.67M
- Employees
- 106
- Next earnings
- —
About Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
- Founded
- 2014
- Listed since
- Apr 3, 2020
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.